These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38395023)

  • 1. Modes of responsibility in disclosing cancer genetic test results to relatives: An analysis of Swiss and Korean narrative data.
    Aceti M; Caiata-Zufferey M; Pedrazzani C; Schweighoffer R; Kim SY; Baroutsou V; Katapodi MC; Kim S;
    Patient Educ Couns; 2024 Jun; 123():108202. PubMed ID: 38395023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using a Tailored Digital Health Intervention for Family Communication and Cascade Genetic Testing in Swiss and Korean Families With Hereditary Breast and Ovarian Cancer: Protocol for the DIALOGUE Study.
    Kim S; Aceti M; Baroutsou V; Bürki N; Caiata-Zufferey M; Cattaneo M; Chappuis PO; Ciorba FM; Graffeo-Galbiati R; Heinzelmann-Schwarz V; Jeong J; Jung MM; Kim SW; Kim J; Lim MC; Ming C; Monnerat C; Park HS; Park SH; Pedrazzani CA; Rabaglio M; Ryu JM; Saccilotto R; Wieser S; Zürrer-Härdi U; Katapodi MC
    JMIR Res Protoc; 2021 Jun; 10(6):e26264. PubMed ID: 34114954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Communication about positive BRCA1 and BRCA2 genetic test results and uptake of testing in relatives in a diverse Asian setting.
    Lee DS; Meiser B; Mariapun S; Hassan T; Yip CH; Mohd Taib NA; Teo SH; Thong MK; Yoon SY
    J Genet Couns; 2021 Jun; 30(3):720-729. PubMed ID: 33245177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family communication matters: the impact of telling relatives about unclassified variants and uninformative DNA-test results.
    Vos J; Jansen AM; Menko F; van Asperen CJ; Stiggelbout AM; Tibben A
    Genet Med; 2011 Apr; 13(4):333-41. PubMed ID: 21358410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol.
    Katapodi MC; Viassolo V; Caiata-Zufferey M; Nikolaidis C; Bührer-Landolt R; Buerki N; Graffeo R; Horváth HC; Kurzeder C; Rabaglio M; Scharfe M; Urech C; Erlanger TE; Probst-Hensch N; Heinimann K; Heinzelmann-Schwarz V; Pagani O; Chappuis PO
    JMIR Res Protoc; 2017 Sep; 6(9):e184. PubMed ID: 28931501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial and clinical factors of probands impacting intrafamilial disclosure and uptake of genetic testing among families with BRCA1/2 or MMR gene mutations.
    Alegre N; Perre PV; Bignon YJ; Michel A; Galibert V; Mophawe O; Corsini C; Coupier I; Chiesa J; Robert L; Bernhard L; Picot MC; Bertet H; Macioce V; Bastide N; Solassol J; Rey JM; Thomas F; Carton S; Pujol P
    Psychooncology; 2019 Aug; 28(8):1679-1686. PubMed ID: 31152683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability and Usability of the Family Gene Toolkit for Swiss and Korean Families Harboring
    Baroutsou V; Duong V; Signorini A; Saccilotto R; Ciorba FM; Bürki N; Caiata-Zufferey M; Ryu JM; Kim SW; Lim MC; Monnerat C; Zürrer-Härdi U; Kim J; Heinimann K; Graffeo R; Park JS; Rabaglio M; Chappuis PO; Kim S; Katapodi MC; On Behalf Of The Cascade And K-Cascade Consortia
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
    Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
    Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).
    Hawranek C; Ehrencrona H; Öfverholm A; Hellquist BN; Rosén A
    Trials; 2023 Dec; 24(1):810. PubMed ID: 38105176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.
    Wagner Costalas J; Itzen M; Malick J; Babb JS; Bove B; Godwin AK; Daly MB
    Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):11-8. PubMed ID: 12704633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Communicating BRCA1/2 genetic test results within the family: a qualitative analysis.
    Dancyger C; Wiseman M; Jacobs C; Smith JA; Wallace M; Michie S
    Psychol Health; 2011 Aug; 26(8):1018-35. PubMed ID: 21797732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives.
    Vos J; Menko F; Jansen AM; van Asperen CJ; Stiggelbout AM; Tibben A
    Fam Cancer; 2011 Mar; 10(1):87-96. PubMed ID: 20852944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Communication Chain of Genetic Risk: Analyses of Narrative Data Exploring Proband-Provider and Proband-Family Communication in Hereditary Breast and Ovarian Cancer.
    Pedrazzani C; Aceti M; Schweighoffer R; Kaiser-Grolimund A; Bürki N; Chappuis PO; Graffeo R; Monnerat C; Pagani O; Rabaglio M; Katapodi MC; Caiata-Zufferey M
    J Pers Med; 2022 Jul; 12(8):. PubMed ID: 36013197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitated cascade testing (FaCT): a randomized controlled trial.
    Nitecki R; Moss HA; Watson CH; Urbauer DL; Melamed A; Lu KH; Lipkin SM; Offit K; Rauh-Hain JA; Frey MK
    Int J Gynecol Cancer; 2021 May; 31(5):779-783. PubMed ID: 33443030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When to break the news and whose responsibility is it? A cross-sectional qualitative study of health professionals' views regarding disclosure of BRCA genetic cancer risk.
    Young AL; Butow PN; Tucker KM; Wakefield CE; Healey E; Williams R
    BMJ Open; 2020 Feb; 10(2):e033127. PubMed ID: 32102811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Openness of Communication in Families With Hereditary Breast and Ovarian Cancer Syndrome: Natural Language Processing Analysis.
    Baroutsou V; Cerqueira Gonzalez Pena R; Schweighoffer R; Caiata-Zufferey M; Kim S; Hesse-Biber S; Ciorba FM; Lauer G; Katapodi M;
    JMIR Form Res; 2023 Jan; 7():e38399. PubMed ID: 36656633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences of BRCA1/2 Gene Mutation-Positive Women With Cancer in Communicating Genetic Risk to Their Relatives.
    Seven M; Shah LL; Daack-Hirsch S; Yazici H
    Cancer Nurs; 2021 May-Jun 01; 44(3):E142-E150. PubMed ID: 32022782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Double Helix: Applying an Ethic of Care to the Duty to Warn Genetic Relatives of Genetic Information.
    Weaver M
    Bioethics; 2016 Mar; 30(3):181-7. PubMed ID: 26194147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.